MENU
+Compare
KZIA
Stock ticker: NASDAQ
AS OF
Dec 23, 04:59 PM (EDT)
Price
$2.98
Change
-$0.04 (-1.32%)
Capitalization
13.15M

KZIA Kazia Therapeutics Limited Forecast, Technical & Fundamental Analysis

a company, which engages in the business of pharmaceutical research and development

Industry Biotechnology
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for KZIA with price predictions
Dec 20, 2024

KZIA in upward trend: price may ascend as a result of having broken its lower Bollinger Band on December 09, 2024

KZIA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 44 cases where KZIA's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 03, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on KZIA as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

KZIA moved below its 50-day moving average on December 03, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for KZIA crossed bearishly below the 50-day moving average on December 09, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KZIA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for KZIA entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.474) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). KZIA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (5.444) is also within normal values, averaging (256.215).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. KZIA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KZIA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
KZIA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a company, which engages in the business of pharmaceutical research and development

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
300 Barangaroo Avenue
Phone
+61 294724101
Employees
16
Web
https://www.kaziatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
KAUIX5.950.07
+1.19%
Federated Hermes Kaufmann IS
HSMFX12.830.06
+0.47%
Hartford Small Cap Value F
RPFFX10.500.03
+0.29%
Royce Premier Service
RCEAX8.620.01
+0.12%
RBC China Equity A
MPLIX13.220.01
+0.08%
Praxis International Index I

KZIA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, KZIA has been loosely correlated with HOOK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if KZIA jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KZIA
1D Price
Change %
KZIA100%
-0.33%
HOOK - KZIA
66%
Loosely correlated
-5.61%
FRES - KZIA
56%
Loosely correlated
-2.60%
ALRN - KZIA
36%
Loosely correlated
-0.57%
CLNN - KZIA
33%
Poorly correlated
+2.33%
RVMD - KZIA
29%
Poorly correlated
+1.78%
More